Non-specific immunoadsorption in patients with dilated cardiomyopathy: Mechanisms and clinical effects

International Journal of Cardiology

Volumn 112, Issue 1, 2006, Pages 30-33

  Felix, Stephan B ^a   Staudt, Alexander ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cardiac antibodies; Dilated cardiomyopathy; Immunoadsorption

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G3;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; CLINICAL FEATURE; CONFOCAL LASER MICROSCOPY; CONGESTIVE CARDIOMYOPATHY; FOLLOW UP; GOODPASTURE SYNDROME; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HUMAN; HUMORAL IMMUNITY; IMMUNOADSORPTION; IMMUNOGLOBULIN STRUCTURE; LUPUS ERYTHEMATOSUS; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; THERAPY EFFECT;

ANTIBODY FORMATION; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CARDIOMYOPATHY, DILATED; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MYOCARDITIS;

EID: 33747342462     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.05.014     Document Type: Article

References (35)

1. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93 (1996) 841-842
2. Dec G.W., Palacios I.F., Fallon J.T., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 312 (1985) 885-890
3. Feldman A.M., and McNamara D.M. Myocarditis. N Engl J Med 343 (2000) 1388-1398
4. Bowles N.E., Richardson P.J., Olsen E.G.J., and Archard L.C. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 17 (1986) 1120-1123
5. Kandolf R., Ameis D., Kirschner P., Canu A., and Hofschnieder P.H. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A 84 (1987) 6272-6276
6. Pauschinger M., Bowles N.E., Fuentes-Garcia F.J., et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99 (1999) 1348-1354
7. Liu P.P., and Mason J.W. Advances in the understanding of myocarditis. Circulation 104 (2001) 1076-1082
8. Magnani J.W., and Dec G.W. Myocarditis current trends in diagnosis and treatment. Circulation 113 (2006) 876-890
9. Kühl U., Noutsias M., and Schultheiss H.P. Immunohistochemistry in dilated cardiomyopathy. Eur Heart J 16 Suppl O (1995) 100-106
10. Wojnicz R., Nowalany-Kozielska E., Wodniecki J., et al. Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. Eur Heart J 19 (1998) 1564-1572
11. Noutsias M., Seeberg B., Schultheiss H.P., and Kühl U. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99 (1999) 2124-2131
12. Schultheiss H.P., Kuhl U., Janda I., Melzner B., Ulrich G., and Morad M. Antibody-mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 168 (1988) 2102-2119
13. Caforio A.L., Grazzini M., Mann J.M., et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85 (1992) 1734-1742
14. Wallukat G., Wollenberger A., Morwinski R., and Pitschner H.F. Antibeta1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 27 (1995) 397-406
15. Fu L.X., Magnusson Y., and Bergh C.H. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91 (1993) 1964-1968
16. Baba A., Yoshikawa T., and Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 1153-1159
17. Felix S.B., Staudt A., Landsberger M., et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39 (2002) 646-652
18. Fu M.L., Schulze W., Wallukat G., Hjalmarson A., and Hoebeke J. A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits. Clin Immunol Immunopathol 78 (1996) 203-207
19. Matsui S., Fu M.L.X., Katsuda S., et al. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 29 (1997) 641-655
20. 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113 (2004) 1419-1429
21. Nishimura H., Okazaki T., Tanaka Y., et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291 (2001) 319-322
22. Okazaki T., Tanaka Y., Nishio R., et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9 (2003) 1477-1483
23. Bygren P., Freiburghaus C., Lindholm T., Simonsen O., Thysell H., and Weislander J. Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet 2 (1985) 1295-1296
24. Palmer A., Gjorstrup P., Severn A., Welsh K., and Traube D. Treatment of systemic lupus erythematodes by extracorporeal immunoadsorption. Lancet 2 (1988) 272
25. Dörffel W.V., Felix S.B., Wallukat G., et al. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 95 (1997) 1994-1997
26. Felix S.B., Staudt A., Dörffel W.V., et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35 (2000) 1590-1598
27. Müller J., Wallukat G., Dandel M., et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101 (2000) 385-391
28. Staudt A., Schaper F., Stangl V., et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103 (2001) 2681-2686
29. 1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 20 (2003) 345-350
30. Horn S., Lueking A., Murphy D., et al. Profiling humoral auto-immune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Proteomics 6 (2006) 605-613
31. Staudt A., Staudt Y., Dörr M., et al. Potential role of humoral immunity in cardiac dysfunction of patient suffering from dilated cardiomyopathy. J Am Coll Cardiol 44 (2004) 829-836
32. Bruggemann M., Williams G.T., Bindon C.I., et al. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 166 (1987) 1351-1361
33. Warraich R.S., Noutsias M., Kazak I., et al. Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. Am Heart J 143 (2002) 1076-1084
34. Staudt A., Böhm M., Knebel F., et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106 (2002) 2448-2453
35. Staudt A., Dörr M., Staudt Y., et al. Role of immunoglobulin G-3 subclass in dilated cardiomyopathy-results from protein-A immunoadsorption. Am Heart J 149 (2005) 1-8